Mediq Lietuva - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 2,996,388 | 3,542,367 | 5,258,767 | 7,675,124 | 7,370,890 | 5,044,751 | 4,314,450 | 5,152,112 |
| Profit before tax | 38,643 | 89,532 | 412,722 | 601,491 | 501,079 | 2,830 | 27,900 | 54,186 |
| Net profit | 25,503 | 71,209 | 343,751 | 497,814 | 421,520 | -2,195 | 24,798 | 41,269 |
| Equity | 418,094 | 389,303 | 733,054 | 1,080,868 | 1,102,388 | 750,193 | 674,991 | 616,260 |
| Liabilities | 410,017 | 409,590 | 449,030 | 472,959 | 302,654 | 341,271 | 281,282 | 550,468 |
| Non-current assets | 103,086 | 103,660 | 108,803 | 116,824 | 136,352 | 116,663 | 127,372 | 155,211 |
| Current assets | 725,498 | 699,614 | 1,072,359 | 1,436,044 | 1,266,781 | 973,835 | 826,651 | 1,011,517 |
| Total assets | 828,584 | 803,274 | 1,181,162 | 1,552,868 | 1,403,133 | 1,090,498 | 954,023 | 1,166,728 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 689,733 | 562,844 | 723,592 |
| Social insurance contributions | - | - | - | - | - | 143,212 | 141,149 | 164,598 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +14.1% | +18.2% | +48.5% | +45.9% | -4.0% | -31.6% | -14.5% | +19.4% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 3.1% | 8.9% | 29.1% | 32.1% | 30.0% | -0.2% | 2.6% | 3.5% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 6.1% | 18.3% | 46.9% | 46.1% | 38.2% | -0.3% | 3.7% | 6.7% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 0.9% | 2.0% | 6.5% | 6.5% | 5.7% | 0.0% | 0.6% | 0.8% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 1.3% | 2.5% | 7.8% | 7.8% | 6.8% | 0.1% | 0.6% | 1.1% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 1.0 | 1.1 | 0.6 | 0.4 | 0.3 | 0.5 | 0.4 | 0.9 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 249,699 | 267,348 | 364,769 | 503,287 | 478,111 | 371,394 | 327,679 | 349,296 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Mediq Lietuva - Social security debts
The company had no debts to Sodra
Mediq Lietuva - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-07-28 | 2025-08-06 | 1.0 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Mediq Lietuva, UAB (code 302513086) is a Private Limited Liability Company engaged in the wholesale of pharmaceutical and medical goods. In 2025, the company generated revenue of €5.15M, up 19.4% year on year and 2.1% compared with 2023. Net profit increased to €41.3K in 2025 from €24.8K in 2024, while the company remained close to breakeven in 2023 with a net loss of €2.2K. Profitability improved gradually, with the net margin rising to 0.8% in 2025 from 0.6% in 2024. Balance sheet figures show total assets of €1.17M, equity of €616.3K and liabilities of €550.5K at the end of 2025. Equity represented 52.8% of assets, and debt-to-equity stood at 0.89. Return on equity was 6.7% and return on assets 3.5%, supported by an asset turnover ratio of 4.42x. Revenue per employee was €368.0K, while profit per employee was €2.9K.